A number of evidence-based weight management interventions are now available with different models, and serving different patient/client groups. While positive outcomes are key to the decision making process, so too is the information around how these outcomes were achieved, in what population, how transferable the outcomes would be to the population a service would be aiming to cover and at what cost to the service-provider and or the individual. This paper examines all the UK interventions with recent peer-reviewed evidence of their effectiveness in "realistic" settings and cost-effectiveness, in the context of NICE and SIGN guidelines. It concludes that the evidence-based approaches allow intervention at different stages in the disease-process of obesity which are effective in different settings. Self-referral to commercial agencies, by individuals with relatively low BMI and few medical complications is a reasonable first step. For more severely obese individuals (e.g. BMI >35kg/m 2 ) requiring more medically complicated care, evidence is largely lacking for these services, but the community-based Counterweight Programme is effective and cost-effective in maintaining weight loss >5kg up to 2 years for 30-40% of attenders. For more complicated and resistant obesity, referral to a secondary care-based service can generate short-term weight loss, but 12 months data are unavailable. 
Introduction
The needs of patients and taxpayers are best served if diseases are managed using evidence-based and cost-effective methods, Evidence-based clinical guidelines for obesity and weight management are now well established by The Scottish Intercollegiate Guideline Network (SIGN) (1996 and 2010) in Scotland,
The National Institute of Health and Clinical Excellence (NICE) in England (2006) and in many other countries 1, 2, 3 . United Kingdom (UK) guidelines have noted that many of the studies on interventions were conducted outside the UK, were of short duration, with little or no follow-up, and were poorly reported.
NICE has called for studies of interventions with a minimum of 12 months follow up. Recognising the scale and epidemic nature of obesity, its costs to society, the somewhat chaotic management existing within the UK National Health Service (NHS), and the failure hitherto of any population-based prevention strategy, these Guideline documents have highlighted the need to create effective treatment services in parallel with effective preventive interventions.
There are several emerging issues for primary care and community-based clinical weight management in the United Kingdom (UK). Firstly, the Department of Health "Call to Action on Obesity" in England set a target to reduce the proportion of adults with excess weight by 2020 4 . Noting that since prevention has hitherto failed, with the majority, two-thirds of UK adults now overweight or obese, effective treatment programmes will be increasingly important. Care is currently purchased at local, PCT level in England, moving to local commissioning boards in 2013, and in 2011 the Scottish Government also decided to devolve budgetary responsibility to Health Boards to put in place appropriate weight management interventions. While different local solutions are possible, the choice of intervention must evaluate the disease-burden and costs of rising obesity, particularly of severe obesity (e.g. BMI >40, >50, >60) rising most rapidly and the proven effectiveness of interventions in meeting targets such as those set out in the Department of Health Call to Action, in relation to available local funding.
The present paper reviews recent peer-reviewed evidence on diet and lifestyle-based weight management programmes widely available for use in the UK in primary care/ community settings, in relation to the points made by NICE (2006) outlined above. While the need for new and different therapies is recognised, guidelines stress the primary role of primary care/ community-based interventions because of sheer numbers of potential patients. This paper excludes studies of adjunctive treatments with pharmacotherapy, liquid-diet programmes, meal-replacement therapies and secondary care programmes such as bariatric surgery.
Historically, most published research in weight management has been on pharmaceutical trials or research-centre based interventions. More recently there have been publications from large-scale primary care/ community-based weight management services for adults, in what can be considered realistic settings or within routine care. The results published have varied somewhat, leading to commentaries which have tried to rank them 5 . That ranking process has not always recognised that the interventions as reported were developed for different reasons, and applied to different populations in different settings.
Thus simple comparisons of reported "top-line" results can be misleading. We have attempted to evaluate the recently published programmes in terms of their contexts as well as weight change outcomes, in order to clarify their different roles within improved overall weight management services.
Aim: this review evaluates published evidence on UK primary care/ community-based weight management intervention assessed in 'realistic' settings, focusing on effectiveness and cost-effectiveness of available interventions, the different population served/covered by different interventions, and the limitations of the available interventions.
Methods and data sources
The literature was searched to reach the totality of relevant evidence within the very restricted nature of this paper, which focuses on studies conducted within the UK only, in realistic settings and with at least 12-months follow-up data. A modified systematic approach was therefore used where a PUBMED search was conducted on 26 March 2012 using the following search terms: 'obesity', 'adults', 'UK', 'intervention', 'programme' and with publication date after January 2005. The cut off for papers published after January 
Results
All the publications included demonstrate that clinically beneficial weight change can be achieved for a valuable proportion of patients, through a variety of programme components and with variable resource implications. The programmes which have been reviewed involved groups of obese patients with rather different characteristics, and thus serve somewhat different purposes so direct comparison of "top line"
weight change results would be misleading. Key data are presented in Tables 1 and 2 .
Counterweight: Care is delivered by existing non-specialist staff, such as practice nurses or health care assistants/ support workers, after brief training and then on-the-job mentoring by Counterweight specialist staff. Patients do not pay for the service. This intervention represents a first level of NHS intervention, in primary care, or local pharmacies: 12-month weight-change results are identical whether the programme 6 is delivered by practice nurses or pharmacy staff 9 . Baseline mean BMI of the patients enrolled is high, at 37kg/m 2 and 14% have diabetes which is known to impede weight loss on conventional diets (table 1) In the Lighten Up Study, numbers with 12month data (excluding self-reported data) are very limited ranging from 32/70 (45%) in the pharmacy arm to 67/ 100 (67%) in the Weight Watchers arm. Of note when considering wider application to routine care is that only 8.3% of the obese subjects approached agreed to take part in the study. Of the 1011 recruited to the study 12m follow up is reported for 522 (52%) but only 416 (41%) had follow up weights measured: the remaining 106 providing self-reported weights. This study (albeit with limited numbers) confirms the effectiveness of commercial organisations for at least some subjects with a lower BMI. However a critical detail, missing from the published data, is information on the proportion of the people allocated to a commercial slimming group arm of the trial who continued attendance (by paying to attend additional sessions) with the allocated group beyond the study sessions. This detail is needed to see the actual number of attendances required to result in the reported weight change.
While poor attendance appears to impair outcomes for the primary care programmes, there is limited detail about the attendance at commercial slimming groups. Retention rates were low in both general practice and pharmacy arms of the Lighten Up study (see table 2): the factors affecting retention rates are worthy of further scrutiny. Baseline data indicated a reasonable percentage of men entered the programme which is encouraging, but it is not clear if patient retention was equal between the sexes.
Further detail of the exact programmes would be of value, in particular how the general practice staff were trained or mentored and whether or how programme integrities were assessed.
Services with only short-term published data
NICE recommended in 2006 that 12-month outcomes were essential in weight management intervention outcomes. Programmes which achieve only short-term weight loss are unlikely to provide good value for money. A number of Programmes available in UK primary care/ community settings have published short term outcomes. While of interest, the results and clinical benefits of these interventions must be treated with caution while longer term peer reviewed data is awaited. . The lack of 12 month data so far does not allow any conclusions to be drawn about weight loss maintenance, or for any direct comparison with the other programmes. .
Discussion
This brief review of the evidence-based programmes available for adults in UK indicates that they all generate valuable weight loss, and those with 12 month data are also able to maintain that loss for a reasonable proportion of patients. However, the different programmes serve different aspects of weight management at different stages of patient need. A direct comparison between the weight-change results of the programmes is not appropriate without considering their settings and the patient groups enrolled.
The methods of outcome ascertainment also varied. There is thus no single 'best option' amongst the evidence-based programme, for weight management in primary care/ community settings. Given the scale of the obesity epidemic and range of degrees to which individuals are affected by obesity, careproviders will need a menu of options for optimal weight management in adults. Future studies are needed to identify the most cost-effective approaches for heterogeneous populations requiring weight management at different stages, and randomised trials may not provide the best or most needed evidence 15, 16 .
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Health Economic analysis
Counterweight remains the only service to have published a full Health Economics analysis of cost per Quality Adjusted Life Year, which showed very high cost-effectiveness for its conventional diet and lifestyle-based programme 17 . A cost in the region of £100 per patient was achieved by providing training for non-specialist staff, who then deliver the structured programme to patients. The weight change achieved would be considered clinically important, and cost-effective at a population level with potential to delay clinical problems aggravated by obesity, and thus cost avoidance.
In the Counterweight Health Economic analysis a conservative estimate of the likely clinical benefits from the relatively modest weight losses achieved and maintained was made, using the NICE predictive model: the model only considers the impact of weight change on three clinical areas, although robust evidence exists around the impact of weight on many more clinical problems. In the long term it is clear that the NHS would generate substantial cost-savings if weight management solutions with robust evidence of effectiveness at 12 months such as Counterweight were established sustainably to ensure access to appropriate weight management intervention with 100% coverage across the UK (long-term cost avoidance would be greater than the short-term set-up and implementation costs). 17 It is possible that a cost-effectiveness analysis of Weight Watchers, Rosemary Conley, Slimming World and GCWMS might produce similar results, although setting up specialist facilities such as GCWMS would entail much greater initial costs and evidence from Weight Watchers does point to a much greater reliance on attendance at the group sessions which would either need to be paid for by the public purse or by the individual attending.
The challenges we face are firstly to improve the success rates of existing services, for example through Most analyses indicate that keeping patients engaged in a programme, and attending an optimal number of planned appointments is key to greater success 6, 8 . Interventions need to meet the wishes and expectations of patients, as well as of referring doctors and those actually delivering and those funding the intervention.
Central to overcoming the obesity epidemic is a need to de-mystify obesity and weight loss, and to penalise agencies which purport to offer effective products or services without externally validated evidence that is in the public domain. Quoting average weight-losses based only on "completers" or "attenders" data, for example, can be helpful but only when put in context by also providing retention rates. Anecdotal data must be treated with great caution. While individual case studies can provide a personal and perhaps eye-catching story, but usually to reflect 'best-case scenarios'. Data on outcomes with no detail of loss to follow up may be hiding poor retention and wasted resources. Even with the best service, 20-40% of patients will discontinue, over 12 months and they generate costs. Services which are promoted on the basis of data from "completers" only should be disregarded.
Conclusion
The published evidence suggests that a range of interventions are effective for weight management at different stages in the patient/client pathway, with 10-20% of entered patients able to maintain >5kg weight loss at 12 months. Self-referral to commercial agencies, by individuals with relatively low BMI and few medical complications is a reasonable first step. For more severely obese individuals (e.g. BMI >35kg/m 2 ) requiring more medically complicated care, evidence is largely lacking for these services, but the community-based Counterweight Programme is effective and cost-effective in maintaining weight loss >5kg up to 2 years for 30-35% of attenders. For more complicated and resistant obesity, referral to a secondary care-based service can generate short-term weight loss, but 12 months and longer data are unavailable. Newer services are in development and the primary-care based Counterweight Low Energy
Liquid Diet programme has shown >15kg weight loss, maintained at 12 months for 33% of all patients and 44% of those followed up at 12months 19 . These options should all be considered, with available pharmacotherapy when indicated, before referral for bariatric surgery.
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1.
The representativeness of the study population, or specific sector swerved 2.
Only robust measures of outcome should be accepted i.e. measured not self-reported
3.
Weight loss results can be assessed at 3-6 months, but need to be supported by effective weight maintenance with 12-24 month data 4.
Consider differences in baseline characteristics in particular data on sex distribution, social deprivation, and prevalence of co-morbidities.
5.
Programme uptake and retention should be considered, presenting ITT data.
6.
The degree of programme flexibility and availability of patient choice
7.
Practical details of interventions are required to enable there repetition.
8.
Economic analysis and long term health outcomes, or projected outcomes 9. Appropriateness of stated weight loss targets to patient characteristics, e.g. presence of medical complications
